| Nombre del producto |
Seratrodast |
| Nombre en inglés |
Seratrodast; Seratrodast [USAN:INN]; (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid; A 73001; AA-2414; ABT 001; Abbott 73001; CCRIS 8939; UNII-4U58JM421N; (+-)-2,4,5-Trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic acid; Benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-; 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid; methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate; 7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)-7-phenylheptanoic acid; (±)-2,4,5-Trimethyl-3,6-dioxo-ζ-phenyl-1,4-cyclohexadiene-1-heptanoic acid |
| Fórmula molecular |
C6H9N3O2 |
| Peso Molecular |
155.1546 |
| InChI |
InChI=1/C6H9N3O2/c1-9-5(7)4(3-8-9)6(10)11-2/h3H,7H2,1-2H3 |
| Número de registro CAS |
112665-43-7 |
| Estructura Molecular |
|
| Densidad |
1.351g/cm3 |
| Punto de ebullición |
288.592°C at 760 mmHg |
| Índice de refracción |
1.584 |
| Punto de inflamación |
128.336°C |
| Presión de vapor |
0.002mmHg at 25°C |
| Símbolos de Peligro |
|
| Códigos de Riesgos |
|
| Descripción de Seguridad |
|
|
